Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,731 | 939 | 98.5% |
| Education | $313.85 | 13 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,773 | 56 | $0 (2024) |
| Novo Nordisk Inc | $2,110 | 116 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,524 | 59 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,479 | 84 | $0 (2024) |
| Amgen Inc. | $1,370 | 85 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,229 | 63 | $0 (2024) |
| ABBVIE INC. | $1,174 | 71 | $0 (2024) |
| PFIZER INC. | $1,039 | 76 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $947.83 | 31 | $0 (2024) |
| Amarin Pharma Inc. | $648.94 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,937 | 120 | AstraZeneca Pharmaceuticals LP ($479.84) |
| 2023 | $3,642 | 148 | AstraZeneca Pharmaceuticals LP ($478.60) |
| 2022 | $3,685 | 124 | AstraZeneca Pharmaceuticals LP ($482.10) |
| 2021 | $2,751 | 91 | Novo Nordisk Inc ($421.66) |
| 2020 | $996.62 | 64 | Janssen Pharmaceuticals, Inc ($223.24) |
| 2019 | $1,785 | 111 | AstraZeneca Pharmaceuticals LP ($284.04) |
| 2018 | $2,795 | 155 | Novo Nordisk Inc ($428.26) |
| 2017 | $2,453 | 139 | Boehringer Ingelheim Pharmaceuticals, Inc. ($433.08) |
All Payment Transactions
952 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $122.86 | General |
| Category: Drug Infusion Systems | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardio-renal | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes | ||||||
| 10/05/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: VACCINES | ||||||
| 09/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $38.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 942 | 1,355 | $300,656 | $113,960 |
| 2022 | 10 | 923 | 1,225 | $244,464 | $100,401 |
| 2021 | 12 | 872 | 1,208 | $211,610 | $92,892 |
| 2020 | 11 | 913 | 1,210 | $208,490 | $76,609 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 345 | 692 | $168,156 | $54,429 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 206 | 206 | $51,088 | $24,931 | 48.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 50 | 50 | $26,500 | $13,799 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 175 | $30,100 | $9,789 | 32.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 45 | $6,615 | $3,237 | 48.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $6,208 | $2,455 | 39.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 32 | $3,872 | $1,468 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 46 | $2,668 | $1,316 | 49.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 46 | 46 | $2,576 | $1,287 | 50.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 18 | 18 | $1,350 | $623.16 | 46.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 16 | 18 | $1,116 | $529.24 | 47.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $407.00 | $97.11 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 339 | 626 | $134,324 | $45,742 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 218 | 218 | $50,178 | $26,962 | 53.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 33 | 34 | $16,740 | $9,195 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 134 | $20,003 | $7,632 | 38.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 59 | 59 | $8,260 | $4,044 | 49.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 19 | $6,514 | $2,961 | 45.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 59 | $3,304 | $1,589 | 48.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 41 | 41 | $1,774 | $1,083 | 61.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 15 | $1,511 | $598.74 | 39.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 20 | $1,856 | $593.77 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 343 | 649 | $131,098 | $51,679 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 166 | 166 | $36,354 | $21,039 | 57.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 126 | $17,262 | $7,156 | 41.5% |
About Dr. James Wright, M.D
Dr. James Wright, M.D is a Family Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245234053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Wright, M.D has received a total of $21,045 in payments from pharmaceutical and medical device companies, with $2,937 received in 2024. These payments were reported across 952 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($20,731).
As a Medicare-enrolled provider, Wright has provided services to 3,650 Medicare beneficiaries, totaling 4,998 services with total Medicare billing of $383,862. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Louisville, KY
- Active Since 06/09/2005
- Last Updated 12/01/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245234053
Products in Payments
- XARELTO (Drug) $1,312
- FARXIGA (Drug) $1,183
- JARDIANCE (Drug) $844.11
- VRAYLAR (Drug) $772.64
- Vascepa (Drug) $648.94
- Ozempic (Drug) $604.75
- TRELEGY ELLIPTA (Drug) $598.20
- REXULTI (Drug) $521.85
- UBRELVY (Drug) $386.79
- ENTRESTO (Drug) $380.07
- Otezla (Drug) $359.01
- LEQVIO (Drug) $341.38
- LOKELMA (Drug) $336.83
- SYNCHROMEDII (Device) $331.74
- NURTEC ODT (Drug) $327.79
- SOLIQUA (Drug) $327.25
- EVENITY (Biological) $316.30
- CHANTIX (Drug) $312.34
- Kerendia (Drug) $311.57
- ELIQUIS (Drug) $300.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Louisville
Christopher Rhyne, M.d, M.D
Family Medicine — Payments: $701,120
Dr. Suraj Gathani, M.d, M.D
Family Medicine — Payments: $64,592
Michael Pendleton, Md, MD
Family Medicine — Payments: $29,425
Mandy Whitt, M.d, M.D
Family Medicine — Payments: $23,888
Rosenberg Reyes, M.d, M.D
Family Medicine — Payments: $18,853
Dr. Dennis Gray, M.d, M.D
Family Medicine — Payments: $14,723